Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

VANTAGE6: an open source priVAcy preserviNg federaTed leArninG infrastructurE for Secure Insight eXchange

Autor: Moncada-Torres, Arturo, Martin, Frank, Sieswerda, Melle, Van Soest, Johan, Geleijnse, Gijs

Publikováno v: AMIA Annu Symp Proc

Answering many of the research questions in the field of cancer informatics requires incorporating and centralizing data that are hosted by different parties. Federated Learning (FL) has emerged as a new approach in which a global model can be genera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4636117f95c64cafc9fab67c9e80cdd6
https://europepmc.org/articles/PMC8075508/

Integrated analysis of DNA copy number and gene expression microarray data using gene sets

Autor: Sieswerda Melle, Boetzer Marten, Menezes Renée X, van Ommen Gert-Jan B, Boer Judith M

Publikováno v: BMC Bioinformatics, Vol 10, Iss 1, p 203 (2009)

Abstract Background Genes that play an important role in tumorigenesis are expected to show association between DNA copy number and RNA expression. Optimal power to find such associations can only be achieved if analysing copy number and gene express

Externí odkaz: https://doaj.org/article/e3ea0dc72f8f4d6eb5b441910abd062d

Impact on Quality of Documentation and Workload of the Introduction of a National Information Standard for Tumor Board Reporting.

Autor: Ebben, Kees C. W. J., Sieswerda, Melle S., Luiten, Ernest J. T., Heijns, Joan B., van der Pol, Carmen C., Bessems, Maud, Honkoop, Aafke H., Hendriks, Mathijs P., Verloop, Janneke, Verbeek, Xander A. A. M.

Publikováno v: JCO Clinical Cancer Informatics; 4/23/2020, Vol. 4, p346-356, 11p

Estimating Treatment Effect of Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer Using Bayesian Networks.

Autor: Sieswerda M; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., van Rossum R; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Bermejo I; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Geleijnse G; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Aben K; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Department for Health Evidence, Radboud University Medical Centre, Nijmegen, the Netherlands., van Erning F; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., de Hingh I; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands., Lemmens V; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Dekker A; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Verbeek X; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.

Publikováno v: JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300080.